| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 1,500 | 1,500 | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| INVESTMENT IN APPLIED STEMCELL INC | 52,500 | 52,500 |
| INVESTMENT IN GOLDMAN SACHS - 15865 | 0 | 0 |
| NEXBIO | 571,170 | 571,170 |
| INVESTMENT IN GOLDMAN SACHS - 15866 | 0 | 0 |
| INVESTMENT - INTERACTIVE B-1328 | 0 | 0 |
| INVESTMENT - INTERACTIVE B-1386 | 0 | 0 |
| INVESTMENT - CREDIT SUISSE 0151 | 504,925 | 532,359 |
| INVESTMENT - CREDIT SUISSE 5116 | 574,527 | 546,626 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| BANK FEES | 10 | 10 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| CAPITAL GAIN DISTRIBUTIONS | 5,787 | 5,787 | 5,787 |
| LOSSES FROM PASS-THRU ENTITIES | -377 | -377 | -377 |
| 2013 TAX REFUND | 1,246 | 1,246 | 1,246 |
| OTHER INCOME | 7,148 | 7,148 | 7,148 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INVESTMENT FEES | 9,255 | 9,255 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES | 257 | 257 | 0 |